Please login to the form below

Not currently logged in
Email:
Password:

Envigo appoints Patricia Henahan as chief financial officer

She brings experience from AZ, Eli Lilly and Hospira

Envigo Patricia HenahanResearch company Envigo - formerly known as Huntindon Life Sciences - has appointed Patricia Henahan as its new chief financial officer.

Henahan brings 15 years of financial experience in the life science sector, including senior leadership roles at AstraZeneca, Eli Lilly and MedImmune.

Most recently, she served as vice president of finance for Hospira's US commercial operations.

Brian Cass, chief executive officer at Envigo, said: “I am delighted that Pat has decided to join the team at Envigo.

“Her background in pharmaceuticals and experience across the research and development process will bring valuable insight to our strategic planning as we continue to position Envigo as a leading provider of contract services and research models globally.”

21st June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics